Difference between revisions of "Team:technion"
Line 92: | Line 92: | ||
<span class="btn-bg4"></span> | <span class="btn-bg4"></span> | ||
<div class="sub4"> | <div class="sub4"> | ||
− | <a href=" | + | <a href="https://2015.igem.org/Team:Technion_Israel/Practices/Education">Education</a> |
− | + | <a href="https://2015.igem.org/Team:Technion_Israel/Practices/Publications">Publications</a> | |
− | <a href=" | + | <a href="https://2015.igem.org/Team:Technion_Israel/Practices/Market_Research">Market Research</a> |
− | + | ||
− | <a href=" | + | |
− | + | ||
</div> | </div> | ||
</div> | </div> |
Revision as of 14:05, 16 August 2015
![Team Logo](https://static.igem.org/mediawiki/2015/f/fc/Team_Technion_Logo.png)
page title
Hair loss affects roughly 61 million people in the United States. More than 95% of hair thinning in men is attributed to male pattern baldness, or androgenetic alopecia. The hair loss product market is a multi-billion dollar market: in the United States alone, this market’s annual revenue is 7 billion dollars, with 3.5% annual growth rate from 2007 to 2012, yet a sufficient solution has yet to be made available. The trigger for androgenetic alopecia is believed to be dihydrotestosterone (DHT), a derivative of testosterone. This summer, we are engineering Bacillus Subtilis, a model organism for a bacterium found naturally on the scalp, to secrete 3α-hydroxysteroid dehydrogenase (3-α-HSD). This enzyme reduces DHT to a non-steroidically active compound, using NADPH and NADH as cofactors.
Our project consists of 3 main parts: 3-α-HSD secretion by the bacterium, engineered bacterium for NADPH overproduction, and a comb as a tool to create a user-friendly experience. By synchronizing these parts, we hope to be able to show convincing evidence of DHT breakdown, providing a promising platform for treatment of male pattern baldness!